The next board meeting for Bioline Rx Ltd - ADR is on 15 Aug 2025 for the purpose of BioLine Rx Ltd Second Quarter Earnings Results for 2025See details
Bioline Rx Ltd - ADR has a share price target of US$ 26, revenue growth forecast of -91.1%, and profit growth estimate of 48.6% for FY25, based on top 2 analyst calls.